Letrozole vs. Clomid: Which Fertility Med Is Better?

Published April 5, 2026 · 13 min read

By Dr. Priya Anand

If you have been trying to conceive and your doctor has mentioned ovulation induction medications, you have almost certainly heard two names: Clomid (clomiphene citrate) and letrozole (brand name Femara). These are the two most commonly prescribed oral medications for stimulating ovulation, and the question of which one is better is one I am asked about almost every day in my practice.

The answer depends on your specific diagnosis, your body's response, and what matters most to you in terms of side effects and cost. But the evidence landscape has shifted dramatically in recent years, and what was once a default recommendation of Clomid first has evolved considerably, particularly for women with polycystic ovary syndrome (PCOS).

In this guide, I will explain how each medication works, compare their success rates and side effect profiles based on the best available clinical evidence, and help you understand how to pair either medication with at-home insemination for the best possible outcomes.

How Ovulation Induction Works

Before diving into the comparison, it helps to understand why ovulation induction is needed and how it works at a basic level.

Ovulation, the release of a mature egg from the ovary, is driven by a carefully orchestrated hormonal cascade. The hypothalamus releases gonadotropin-releasing hormone (GnRH), which signals the pituitary gland to produce follicle-stimulating hormone (FSH) and luteinizing hormone (LH). FSH stimulates the growth and maturation of ovarian follicles, and a surge of LH triggers the release of the mature egg.

When this system is not working properly, whether due to PCOS, hypothalamic dysfunction, or unexplained anovulation, ovulation either does not occur or occurs irregularly. Ovulation induction medications intervene in this hormonal cascade to stimulate follicle development and trigger ovulation. Both Clomid and letrozole accomplish this goal, but through fundamentally different mechanisms.

Clomid: How It Works

Clomiphene citrate, marketed as Clomid or Serophene, has been the workhorse of ovulation induction since it was approved by the FDA in 1967. It is a selective estrogen receptor modulator (SERM) that works by blocking estrogen receptors in the hypothalamus and pituitary gland.

When estrogen receptors are blocked, the brain perceives estrogen levels as lower than they actually are. In response, the hypothalamus increases GnRH output, which stimulates the pituitary to produce more FSH and LH. The increased FSH drives follicle development in the ovaries, ideally resulting in the maturation and release of one or more eggs.

The typical Clomid protocol involves taking 50 mg daily for five days, usually starting on cycle day 3 or cycle day 5. If ovulation does not occur at 50 mg, the dose can be increased in subsequent cycles to 100 mg or 150 mg, with 150 mg being the maximum recommended dose.

Clomid Success Rates

Clomid is effective at inducing ovulation in approximately 70 to 80 percent of women with anovulatory infertility. However, ovulation does not guarantee pregnancy. The per-cycle pregnancy rate with Clomid is approximately 10 to 12 percent, with cumulative pregnancy rates of 30 to 40 percent over three to six cycles.

For women with PCOS specifically, Clomid induces ovulation in about 48 to 73 percent of cases, but live birth rates are somewhat lower than ovulation rates suggest, partially due to Clomid's anti-estrogenic effects on the uterine lining (discussed below).

Approximately 15 to 25 percent of women are considered "Clomid-resistant," meaning they do not ovulate even at the maximum dose. These women are typically candidates for switching to letrozole or advancing to injectable gonadotropins.

Clomid Side Effects

Because Clomid blocks estrogen receptors throughout the body (not just in the brain), it can produce several notable side effects:

• Hot flashes: Reported by approximately 10 to 20 percent of women, resulting from the anti-estrogenic effects on the thermoregulatory center
• Mood changes: Irritability, mood swings, and emotional sensitivity are common, affecting roughly 15 percent of users
• Headaches: Occur in approximately 10 to 15 percent of women
• Visual disturbances: Blurred vision, spots, or light sensitivity occur in 1 to 2 percent of users. This side effect, while rare, is a reason to discontinue the medication immediately and contact your provider
• Thin uterine lining: Clomid's anti-estrogenic effects can thin the endometrial lining, potentially making it less receptive to embryo implantation. This is one of the most clinically significant downsides
• Reduced cervical mucus: The anti-estrogenic effect also decreases the quantity and quality of cervical mucus, which can impair sperm transport
• Multiple pregnancy risk: Clomid carries a 5 to 10 percent risk of twins and a less than 1 percent risk of higher-order multiples (triplets or more)

The thinning of the uterine lining and reduction in cervical mucus are particular concerns because they can partially counteract the benefit of inducing ovulation. This paradox, stimulating ovulation while simultaneously creating a less hospitable environment for implantation, is one of the key reasons many reproductive endocrinologists have shifted toward letrozole as a first-line option.

It is worth noting that Clomid is also sometimes prescribed for men with low testosterone or suboptimal sperm parameters. Our article on Clomid for men covers this off-label use in detail.

Letrozole: How It Works

Letrozole (brand name Femara) is an aromatase inhibitor originally developed and FDA-approved for the treatment of hormone-receptor-positive breast cancer in postmenopausal women. Its use for ovulation induction is off-label, meaning it is prescribed based on clinical evidence and physician judgment rather than a specific FDA approval for this purpose. Despite being off-label, it has become the first-line recommendation for ovulation induction in many fertility practices.

Aromatase is the enzyme that converts androgens (like testosterone) into estrogens. By inhibiting aromatase, letrozole temporarily reduces estrogen production. Just like Clomid, this lower estrogen level signals the hypothalamus to increase GnRH, leading to increased FSH production and follicle development.

The critical difference is in the mechanism of estrogen reduction. Clomid blocks estrogen receptors (the brain thinks estrogen is low even though it is present), while letrozole actually reduces estrogen production (the brain detects genuinely lower estrogen levels). This distinction has important practical consequences.

Because letrozole reduces estrogen production rather than blocking receptors, its effects are temporary and fully reversible within the same cycle. As follicles develop and produce their own estrogen, levels rise naturally. This means that by the time ovulation occurs and the uterine lining needs to thicken for implantation, estrogen is back to normal levels. The uterine lining and cervical mucus are not adversely affected the way they can be with Clomid.

The standard letrozole protocol is 2.5 mg daily for five days, starting on cycle day 3 or 5. The dose can be increased to 5.0 mg or 7.5 mg in subsequent cycles if ovulation does not occur at the starting dose.

Letrozole Success Rates

Letrozole produces ovulation in approximately 60 to 85 percent of women with anovulatory infertility, depending on the underlying cause and the dose used. Per-cycle pregnancy rates are approximately 12 to 15 percent, slightly higher than Clomid in most studies.

The most important evidence comparing letrozole to Clomid comes from the landmark NICHD trial published in the New England Journal of Medicine in 2014. This large, multicenter, double-blind, randomized controlled trial enrolled 750 women with PCOS and compared letrozole to Clomid over up to five treatment cycles. The results were decisive:

• Ovulation rate: Letrozole 61.7 percent vs. Clomid 48.3 percent
• Live birth rate: Letrozole 27.5 percent vs. Clomid 19.1 percent
• Multiple pregnancy rate: Letrozole 3.4 percent vs. Clomid 7.4 percent

This trial was a game-changer in reproductive medicine and is the primary reason that letrozole has become the first-line recommendation for ovulation induction in PCOS, as endorsed by the American Society for Reproductive Medicine (ASRM) and other professional organizations.

Letrozole Side Effects

Letrozole tends to produce milder side effects than Clomid, partly because its mechanism does not involve systemic estrogen receptor blockade:

• Fatigue: The most commonly reported side effect, affecting approximately 10 to 15 percent of users
• Dizziness: Reported by roughly 5 to 10 percent of users
• Headache: Occurs at rates similar to Clomid
• Hot flashes: Can occur but are generally less frequent and less severe than with Clomid
• Muscle or joint aches: Occasionally reported
• No adverse effect on uterine lining: Unlike Clomid, letrozole does not thin the endometrium
• No adverse effect on cervical mucus: Cervical mucus quality is preserved
• Lower multiple pregnancy risk: Approximately 3 to 4 percent risk of twins, lower than Clomid

Earlier concerns about potential teratogenicity (birth defects) associated with letrozole have been addressed by multiple large studies and meta-analyses that found no increased risk of birth defects compared with Clomid or natural conception. The Cleveland Clinic and other major medical centers now consider letrozole safe for fertility use.

Head-to-Head Comparison

Which Is Better for PCOS?

The evidence is clear: for women with PCOS, letrozole is the superior first-line option. The NICHD trial described above demonstrated statistically significant improvements in both ovulation and live birth rates with letrozole compared to Clomid. This finding has been supported by subsequent meta-analyses and is reflected in current clinical guidelines from ASRM and the Endocrine Society.

The reasons letrozole outperforms Clomid in PCOS go beyond the headline success rates. Women with PCOS often have elevated estrogen levels and are particularly susceptible to Clomid's anti-estrogenic side effects on the uterine lining. Because letrozole does not block estrogen receptors, it avoids this problem entirely. Additionally, letrozole tends to produce a single dominant follicle more consistently than Clomid, reducing the risk of multiple pregnancy, which is already elevated in women with PCOS.

Some women with PCOS who are "Clomid-resistant" (fail to ovulate on Clomid) will respond successfully to letrozole, making it a valuable second-line option even for those who have already tried Clomid without success. For a deeper dive into PCOS-specific fertility strategies, see our PCOS and conception guide.

Pairing Fertility Meds with At-Home Insemination

One of the most common questions I receive is whether it is possible to use fertility medications like letrozole or Clomid while doing insemination at home rather than in a clinic. The answer is yes, and many women do this successfully.

Here is how a typical medicated at-home insemination cycle works:

1. Get your prescription: Your doctor or reproductive endocrinologist prescribes the medication and monitors your cycle with blood work and/or ultrasound. This medical supervision is essential because these medications need proper dosing and monitoring to be used safely.
2. Take the medication: Follow your prescribed protocol, typically five days of the medication starting on cycle day 3 or 5.
3. Monitor with ultrasound (if recommended): Your doctor may perform a mid-cycle ultrasound to check follicle development and endometrial thickness. This is particularly important during your first medicated cycle to ensure you are responding appropriately and not developing too many follicles.
4. Track your LH surge: Begin using ovulation predictor kits (OPKs) according to your doctor's instructions, typically starting a few days after your last medication dose. A positive OPK indicates your LH surge, meaning ovulation will likely occur within 24 to 36 hours. For detailed guidance on timing, see our ICI timing with ovulation guide.
5. Perform insemination: Once you detect your LH surge, perform your insemination within 12 to 36 hours. Many fertility specialists recommend inseminating twice, once on the day of the positive OPK and again 12 to 24 hours later, to maximize coverage of the fertile window.

The CryoBaby Kit is designed to work seamlessly with medicated cycles when using frozen donor sperm. It includes everything you need for the insemination step, while your doctor handles the medical supervision of the medication. For a comprehensive guide to maximizing your insemination success, see our at-home insemination success tips.

A few important notes about medicated ICI cycles:

• Your ovulation timing may shift. Medicated cycles often cause ovulation earlier or later than your natural cycle. Do not rely on previous cycle data for timing; use OPKs every cycle.
• Multiple follicles increase twin risk. If your monitoring ultrasound shows more than two or three mature follicles, your doctor may advise against proceeding with insemination that cycle due to the risk of higher-order multiples.
• Trigger shots can improve timing. Some doctors prescribe an hCG trigger shot (like Ovidrel) to precisely time ovulation. If you receive a trigger, ovulation typically occurs 36 to 40 hours later, giving you a clear window for insemination.

Supporting your body during medicated cycles with a comprehensive prenatal supplement is important. Her Daily Formula provides the nutritional foundation that supports healthy follicle development, optimal uterine lining, and early embryo implantation. Our ovulation tracking for insemination guide covers the practical details of timing your attempts.

Cost Comparison

Both letrozole and Clomid are available as generics, making them among the most affordable fertility treatments available. Here is a general cost breakdown:

Clomid (clomiphene citrate): Generic clomiphene costs approximately $10 to $50 per cycle, depending on the dose and your pharmacy. Most insurance plans cover it, and discount programs like GoodRx can bring the cost even lower. Brand-name Clomid, if still available, can cost $50 to $100 or more.

Letrozole (Femara): Generic letrozole costs approximately $5 to $30 per cycle, often slightly less than generic clomiphene. Insurance coverage varies because letrozole's use for fertility is off-label, but many pharmacies carry it as an inexpensive generic. Brand-name Femara is significantly more expensive at $300 or more per cycle, but there is rarely a reason to use the brand name over the generic.

Monitoring costs: The medication itself is only part of the cost. Monitoring with blood work and ultrasounds can add $200 to $500 per cycle if not covered by insurance. This monitoring is recommended for safety but is the same regardless of which medication you use.

Compared with other fertility treatments like injectable gonadotropins ($1,000 to $5,000 per cycle), IUI ($500 to $2,000 per cycle), or IVF ($12,000 to $25,000 per cycle), oral ovulation induction medications combined with at-home insemination represent one of the most cost-effective approaches to assisted conception.

Frequently Asked Questions

Is letrozole better than Clomid for getting pregnant?

For women with PCOS, the evidence clearly favors letrozole. The landmark NICHD trial found that letrozole produced higher ovulation rates and higher live birth rates compared with Clomid in women with PCOS. For women without PCOS who have unexplained infertility, the two medications show more comparable results, and the choice may depend on individual factors and side effect tolerance.

Can I use Clomid or letrozole with at-home insemination?

Yes. Many women successfully combine prescribed fertility medications with at-home insemination. Your doctor prescribes and monitors the medication cycle, and you perform the insemination at home during your fertile window. The key is accurate ovulation tracking, as medicated cycles can shift your ovulation timing compared with natural cycles. OPKs are especially important for timing insemination during medicated cycles.

What are the main side effects of Clomid vs. letrozole?

Clomid's most common side effects include hot flashes, mood swings, headaches, visual disturbances, and anti-estrogenic effects that can thin the uterine lining and reduce cervical mucus quality. Letrozole tends to have milder side effects, with fatigue, dizziness, and mild headaches being most common. Letrozole does not have the anti-estrogenic effects on the uterine lining and cervical mucus, which is one reason many reproductive endocrinologists now prefer it.

How many cycles of Clomid or letrozole should I try before moving on?

Most reproductive endocrinologists recommend trying three to six medicated cycles before considering a change in approach. If you are ovulating on the medication but not conceiving after three to four cycles, your doctor may increase the dose, switch to the other medication, add additional interventions like trigger shots or IUI, or recommend further diagnostic testing. Using the same medication for more than six cycles without success is generally not recommended.